Loading…

A Possible Mechanism of Modulation of Slow Sodium Channels in the Sensory Neuron Membrane by Short Peptides

The possible mechanisms of ligand–receptor binding of arginine-containing tetrapeptides with the Na V 1.8 channels in the primary sensory neuron were investigated. Ac-RERR-NH 2 tetrapeptide, acting outside the neuronal membrane, was found to decrease voltage sensitivity of the examined channels. In...

Full description

Saved in:
Bibliographic Details
Published in:Biophysics (Oxford) 2021-07, Vol.66 (4), p.579-588
Main Authors: Rogachevsky, I. V., Kalinina, A. D., Penniyaynen, V. A., Terekhin, S. G., Podzorova, S. A., Krylov, B. V., Plakhova, V. B.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The possible mechanisms of ligand–receptor binding of arginine-containing tetrapeptides with the Na V 1.8 channels in the primary sensory neuron were investigated. Ac-RERR-NH 2 tetrapeptide, acting outside the neuronal membrane, was found to decrease voltage sensitivity of the examined channels. In contrast, the Ac-REАR-NH 2 tetrapeptide did not exhibit the same effect. Conformational analysis was used to investigate the mechanisms of ligand–receptor binding of a number of studied short peptides; it suggested that positively charged guanidine side chains of two arginine residues played a key role in peptide binding. Another amino-acid residue (glutamic acid) should be located between these two arginine residues. Our calculations demonstrated that the mechanism of ligand–receptor binding could not be implemented if the distance between the guanidine groups in short peptide molecules was less than a defined threshold value. The results allow one to conclude that the Ac-RERR-NH 2 tetrapeptide and several other peptides capable of binding with the Na V 1.8 channel by the same molecular mechanism have the potential to become novel peripheral analgesic drugs.
ISSN:0006-3509
1555-6654
DOI:10.1134/S0006350921040205